The global sleep apnea devices market is expected to grow at a compound annual growth rate (CAGR) of 16.6% during the forecast period from 2014 to 2019, according to Research and Markets’ “Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices)—Global Forecast to 2019.” North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia.
The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years, the report states. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019.
In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into PAP devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market.